Views: 1,302 | Downloads:
23
| Responses: 0
XML | Respond to this article | Alert & updates | Request permissions | Email to a friend |
Original ArticleOpen Access
In Vitro Susceptibility Testing of Levofloxacin and Ofloxacin by Microliter Plate Alamar Blue Against Multidrug and Non Multidrug Resistant Mycobacterium tuberculosis in Thailand
Antituberculous drugs for current therapy of multidrugs resistant tuberculosis (MDR-TB)
are limited. The
in vitro
susceptibility of
Mycobacterium tuberculosis
(MTB) as well as MDR-
TB with other antibiotic drugs were determined in order to find alternative drugs for the treat-
ment of MDR-TB. Forty-seven MDR-TB and 62 MTB of clinical isolates were tested against
levofloxacin and ofloxacin. The MDR-TB at the MIC
90
of levofloxacin and ofloxcain were
1
J.lg/
ml and 2 J.lg/ml, respectively. Of these MTB, the MIC
90
of both drugs were 0.5 f.lg/ml and 1
f.lg/ml, respectively. It seemed that levofloxacin MICs of both MDR-TB and MTB were one
dilution less than ofloxcin. The promising activity of ofloxacin and levofloxacin against MDR-
TB and MTB suggest that both drugs could be used as second-line drugs for MDR-TB or as a
good alternative antituberculous drug for patients who have intolerance to the first line drug.
Key word :
Mycobacterium tuberculosis,
Tuberculosis, Levofloxacin, Ofloxacin, Alamar Blue
are limited. The
in vitro
susceptibility of
Mycobacterium tuberculosis
(MTB) as well as MDR-
TB with other antibiotic drugs were determined in order to find alternative drugs for the treat-
ment of MDR-TB. Forty-seven MDR-TB and 62 MTB of clinical isolates were tested against
levofloxacin and ofloxacin. The MDR-TB at the MIC
90
of levofloxacin and ofloxcain were
1
J.lg/
ml and 2 J.lg/ml, respectively. Of these MTB, the MIC
90
of both drugs were 0.5 f.lg/ml and 1
f.lg/ml, respectively. It seemed that levofloxacin MICs of both MDR-TB and MTB were one
dilution less than ofloxcin. The promising activity of ofloxacin and levofloxacin against MDR-
TB and MTB suggest that both drugs could be used as second-line drugs for MDR-TB or as a
good alternative antituberculous drug for patients who have intolerance to the first line drug.
Key word :
Mycobacterium tuberculosis,
Tuberculosis, Levofloxacin, Ofloxacin, Alamar Blue
Download:
PDF